𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Trends in post–liver transplant survival in patients with hepatitis C between 1991 and 2001 in the united states

✍ Scribed by Paul J. Thuluvath; Karen L. Krok; Dorry L. Segev; Hwan Y. Yoo


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
393 KB
Volume
13
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

✦ Synopsis


It has been suggested that the post-liver transplantation (LT) survival rate of patients with hepatitis C virus infection (HCV) has declined in recent years. To compare the outcome of LT in patients with HCV at various time intervals between 1991 and 2001, we used United Network for Organ Sharing data to compare the post-LT survival of adult patients (age Ͼ18 years) with HCV with those without HCV. Of the 37,101 patients who underwent LT during the study period, 28,193 patients (HCV 7,459 and 20,734 non-HCV) were eligible for the study. On the basis of the time of transplantation, patients were divided into 3 groups: 1991-1993 (period 1), 1994-1997 (period 2), and 1998-2001 (period 3). The patient and graft survival rates were adjusted for other known confounding variables that influenced outcomes. The 3-year patient survival rate was lower in HCV patients compared with non-HCV recipients (78.5% vs. 81.4%, hazard ratio 1.14, 95% confidence interval 1.05-1.23, P ϭ 0.001). The graft (72.8%, 71.0%, and 69.8%) and patient (77.4%, 79.6%, and 78.5%) survival of HCV patients remained unchanged during study periods 1-3, respectively. However, the graft and patient survival rates of non-HCV recipients improved markedly during study periods 2 and 3 compared with period 1. The graft and patient survival has remained unchanged between 1991 and 2001 in HCV recipients, but during the same period, there was a great improvement in survival among non-HCV recipients.


📜 SIMILAR VOLUMES


Post–liver transplant survival in hepati
✍ Jacqueline G. O'Leary; Henry Randall; Nicholas Onaca; Linda Jennings; Göran B. K 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 1 views

Outcomes after orthotopic liver transplantation for chronic hepatitis C have been reported to be worsening over the last 2 decades. We analyzed our center's experience over 15 years to identify trends in post-orthotopic liver transplantation survival in patients with and without hepatitis C virus in

Patient and graft survival in hepatitis
✍ Mark W. Russo; Joseph Galanko; Kimberly Beavers; Michael W. Fried; Roshan Shrest 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

End stage liver disease from chronic hepatitis C is the leading indication for liver transplantation in the United States. Small studies suggest that recurrent hepatitis C may be more common and occur earlier after living donor liver transplantation compared to deceased donor liver transplantation.

Survival and recurrence of hepatitis C a
✍ Jean-Charles Duclos-Vallée; Cyrille Féray; Mylène Sebagh; Elina Teicher; Anne-Ma 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB 👁 2 views

Liver transplantation in patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) is a recent indication. In a single center, we have compared the survival and severity of recurrent HCV infection after liver transplantation in HIV-HCV-coinfected and HCV-monoinfected pa

Plasma cell hepatitis in hepatitis C vir
✍ Stephen C. Ward; Thomas D. Schiano; Swan N. Thung; M. Isabel Fiel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

Plasma cell hepatitis (PCH) is characterized by plasma cell infiltration seen in allografts of patients who underwent liver transplantation (LT) for conditions other than autoimmune hepatitis. We identified 40 PCH patients who underwent LT for hepatitis C virus (HCV) by searching our pathology datab

The changing survival of patients with m
✍ Martin A. Weinstock; Josefina F. Reynes 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 3 views

The authors sought to evaluate trends in survival among a population-based group of patients with mycosis fungoides, in response to informal evidence of improved prognosis and concerns about the influence of detection bias on incidence data. METHODS. Data used in this study were drawn from the Surve